Prognostic scoring systems in chronic myeloid leukaemia

Area of Science:

• Medical Statistics
• Hematology
• Oncology

Background:

• Prognostic scores are vital in medical statistics for patient stratification.
• Established prognostic models exist for chronic myeloid leukaemia (CML).
• Historically, CML models focused on survival, but endpoints have broadened.

Purpose of the Study:

• To review the evolution and application of prognostic scores in CML.
• To provide recommendations for the current use of these scores.
• To anticipate future advancements in CML prognostication.

Main Methods:

• Literature review of prognostic models in CML.
• Analysis of the shift in endpoints used in CML prognostication.
• Discussion of current and future applications of prognostic scores.

Main Results:

• CML prognostic models have transitioned from survival-only to diverse endpoints.
• Newer therapeutic options necessitate updated prognostic criteria.
• Key endpoints now include molecular remission and progression-free survival.

Conclusions:

• Adapting CML prognostic models is crucial with evolving treatments.
• Models should integrate molecular remission, progression-free survival, and CML-related survival.
• Refined, internationally validated scores will enhance individualized patient prognostication and outcomes.